Insider Transactions in Q1 2025 at Bei Gene, Ltd. (BGNE)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 18
2025
|
Xiaodong Wang Director |
SELL
Open market or private sale
|
Direct |
41,760
-44.49%
|
$10,899,360
$261.12 P/Share
|
|
Mar 18
2025
|
Xiaodong Wang Director |
BUY
Exercise of conversion of derivative security
|
Direct |
41,760
+50.0%
|
$250,560
$6.5 P/Share
|
|
Mar 14
2025
|
Xiaobin Wu President and COO |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
Mar 11
2025
|
Xiaodong Wang Director |
SELL
Bona fide gift
|
Direct |
158,717
-3.03%
|
-
|
|
Mar 10
2025
|
John Oyler Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
41,210
-39.18%
|
$9,972,820
$242.91 P/Share
|
|
Mar 10
2025
|
John Oyler Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
41,210
+50.0%
|
$247,260
$6.5 P/Share
|
|
Mar 10
2025
|
John Oyler Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
497,822
+7.55%
|
$0
$0.5 P/Share
|
|
Mar 07
2025
|
John Oyler Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
58,590
-32.93%
|
$14,647,500
$250.34 P/Share
|
|
Mar 07
2025
|
John Oyler Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
58,590
+50.0%
|
$351,540
$6.5 P/Share
|
|
Mar 07
2025
|
John Oyler Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
708,747
+11.23%
|
$0
$0.5 P/Share
|
|
Mar 06
2025
|
John Oyler Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
40,109
-52.81%
|
$10,428,340
$260.48 P/Share
|
|
Mar 06
2025
|
John Oyler Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,109
+50.0%
|
$240,654
$6.5 P/Share
|
|
Mar 06
2025
|
John Oyler Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
486,161
+9.04%
|
$0
$0.5 P/Share
|
|
Mar 05
2025
|
John Oyler Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
201,084
+4.36%
|
-
|
|
Mar 05
2025
|
Aaron Rosenberg Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,581
+22.52%
|
-
|
|
Mar 05
2025
|
Chan Henry Lee SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
40,209
+14.04%
|
-
|
|
Mar 05
2025
|
Lai Wang Global Head of R&D |
BUY
Grant, award, or other acquisition
|
Direct |
69,251
+6.54%
|
-
|
|
Mar 05
2025
|
Xiaobin Wu President and COO |
SELL
Open market or private sale
|
Direct |
51,921
-66.69%
|
$13,551,381
$261.88 P/Share
|
|
Mar 05
2025
|
Xiaobin Wu President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
51,921
+48.18%
|
$7,476,624
$144.8 P/Share
|
|
Mar 05
2025
|
Xiaobin Wu President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
103,883
+8.12%
|
-
|
|
Mar 04
2025
|
Xiaodong Wang Director |
SELL
Open market or private sale
|
Indirect |
8,146
-42.76%
|
$2,069,084
$254.67 P/Share
|
|
Mar 03
2025
|
John Oyler Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
101,000
-35.47%
|
$24,644,000
$244.98 P/Share
|
|
Mar 03
2025
|
John Oyler Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
101,000
+50.0%
|
$606,000
$6.5 P/Share
|
|
Mar 03
2025
|
John Oyler Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,220,531
+22.52%
|
$0
$0.5 P/Share
|
|
Feb 28
2025
|
Xiaobin Wu President and COO |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
Feb 28
2025
|
Baker Bros. Advisors LP |
SELL
Open market or private sale
|
Indirect |
732,827
-7.69%
|
$190,535,020
$260.0 P/Share
|
|
Feb 27
2025
|
Chan Henry Lee SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
1,205
-100.0%
|
$331,375
$275.0 P/Share
|
|
Feb 21
2025
|
Chan Henry Lee SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
1,202
-75.87%
|
$310,116
$258.58 P/Share
|
|
Feb 21
2025
|
Lai Wang Global Head of R&D |
SELL
Open market or private sale
|
Indirect |
5,000
-42.67%
|
$1,285,000
$257.41 P/Share
|
|
Feb 20
2025
|
Xiaobin Wu President and COO |
SELL
Open market or private sale
|
Direct |
21,267
-100.0%
|
$5,104,080
$240.07 P/Share
|
|
Feb 20
2025
|
Xiaobin Wu President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
21,267
+50.0%
|
$3,594,123
$169.65 P/Share
|
|
Feb 18
2025
|
Xiaobin Wu President and COO |
SELL
Open market or private sale
|
Direct |
30,654
-78.45%
|
$7,387,614
$241.22 P/Share
|
|
Feb 18
2025
|
Xiaobin Wu President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,654
+50.0%
|
$5,180,526
$169.65 P/Share
|
|
Feb 04
2025
|
Xiaodong Wang Director |
SELL
Open market or private sale
|
Direct |
41,760
-47.05%
|
$9,396,000
$225.64 P/Share
|
|
Feb 04
2025
|
Xiaodong Wang Director |
BUY
Exercise of conversion of derivative security
|
Direct |
41,760
+50.0%
|
$250,560
$6.5 P/Share
|
|
Jan 07
2025
|
Xiaodong Wang Director |
SELL
Open market or private sale
|
Direct |
41,760
-63.13%
|
$7,391,520
$177.42 P/Share
|
|
Jan 07
2025
|
Xiaodong Wang Director |
BUY
Exercise of conversion of derivative security
|
Direct |
41,760
+50.0%
|
$250,560
$6.5 P/Share
|